Oesophageal Cancer Forecast in 18 Major Markets 2017-2027: 10 Year Snapshot by Gender and 5 Year Cohort - Research and Markets

DUBLIN, Apr 5, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Oesophageal Cancer Forecast in 18 Major Markets 2017-2027" report to their offering.

Oesophageal Cancer is an uncontrolled growth of abnormal cells which forms in the lining of the oesophagus.

Epithelial tumours of the oesophagus are responsible for the majority of oesophageal cancers. The majority of oesophageal cancers can be subdivided into two main histological subtypes:

- Adenocarcinomas (AC) - Squamous cell carcinomas (SCC)

This report provides the current incident population for Oesophageal Cancer across 18 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Russia, Turkey, India, China, Japan, Argentina, Brazil, Mexico, Australia, Saudi Arabia and South Africa) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Oesophageal Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

There are several features associated with the development and progression of oesophageal cancer, these include:

- Fistula formation to trachea, bronchi or mediastinum (can be either due to direct tumour progression or iatrogenic effects (e.g. radiation therapy))
- Oesophageal perforation
- Cachexia
- GORD
- Smoking
- Nausea or vomiting
- Coughing

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key comorbid conditions/Features associated with the disease

8. Methodology for quantification of patient numbers

9. Top-line incidence for Oesophageal Cancer

10. Features of Oesophageal Cancer patients

11. Abbreviations used in the report

12. Patient-Based Offering

13. Online Pricing Data and Platforms

14. References

15. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/s2n3h3/oesophageal

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com